Managing ocular allergy in the time of COVID-19

Allergy. 2020 Sep;75(9):2399-2402. doi: 10.1111/all.14361. Epub 2020 May 25.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Ophthalmic
  • Administration, Oral
  • Adrenal Cortex Hormones / therapeutic use*
  • Allergists*
  • Anti-Allergic Agents / therapeutic use
  • Betacoronavirus
  • COVID-19
  • Calcineurin Inhibitors / therapeutic use*
  • Conjunctivitis, Allergic / drug therapy*
  • Coronavirus Infections / epidemiology*
  • Disease Management
  • Histamine Antagonists / therapeutic use*
  • Humans
  • Ophthalmologists*
  • Pandemics
  • Pneumonia, Viral / epidemiology*
  • Practice Guidelines as Topic
  • Practice Patterns, Physicians'*
  • Risk Assessment
  • SARS-CoV-2
  • Seasons

Substances

  • Adrenal Cortex Hormones
  • Anti-Allergic Agents
  • Calcineurin Inhibitors
  • Histamine Antagonists